BCIM
PPH icon

British Columbia Investment Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

British Columbia Investment Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-545,207
Closed -$56.6M – 690
2026
Q1 		$56.6M Sell
545,207
-143,404
-21% -$15.3M 0.33% 54
2025
Q4 		$71M Buy
+688,611
New +$67M 0.37% 47

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

British Columbia Investment Management's PPH Position: Q2 2026 in Review

British Columbia Investment Management sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2026, closing a stake of 545,207 shares — an estimated $56.6M sold.

British Columbia Investment Management first reported a position in PPH in Q4 2025 and held it in 2 quarters. The position peaked at $71M in Q4 2025. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • British Columbia Investment Management reported no remaining VanEck Pharmaceutical ETF position as of Q2 2026 after selling out during the quarter.
  • British Columbia Investment Management sold 545,207 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $56.6M.
  • British Columbia Investment Management first reported a position in VanEck Pharmaceutical ETF in Q4 2025 and held it in 2 quarters.
  • British Columbia Investment Management's VanEck Pharmaceutical ETF position peaked at $71M in Q4 2025.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on British Columbia Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.